SK bioscience, the biopharmaceutical arm of South Korea's SK Group, said on Wednesday it has achieved a "final victory" in a ...

One in five Irish people said they would not take a traditional vaccine, a worldwide research project found. A further one in ...

South Korean vaccine developer SK bioscience has won a final ruling in a patent dispute with Moderna (Nasdaq: MRNA) over key ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...

The Slovak government halted purchases of COVID-19 vaccines on Wednesday pending a review of their safety by the Slovak ...

SK Bioscience announced Wednesday that it has secured a definitive legal victory in its patent invalidation suit against Moderna, successfully challenging the biotech giant’s Korean patent related to ...

On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...

The company is seeking to convert the vaccine’s emergency use authorization received in 2022 into a full approval that would ...

Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.